• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Plasmapheresis and Guillain-Barré syndrome: analysis of prognostic factors and the effect of plasmapheresis.

作者信息

McKhann G M, Griffin J W, Cornblath D R, Mellits E D, Fisher R S, Quaskey S A

机构信息

Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD.

出版信息

Ann Neurol. 1988 Apr;23(4):347-53. doi: 10.1002/ana.410230406.

DOI:10.1002/ana.410230406
PMID:3382169
Abstract

The time course of recovery in the Guillain-Barré syndrome is known to vary widely, but factors associated with differences have not been previously defined. In this study we used multivariate analysis to identify such factors and to determine whether the presence or absence of specific factors would influence treatment decisions, particularly the use of plasmapheresis. Data from 245 patients randomized into conventional and plasmapheresis arms were used to assess the time to walk independently (Grade 2), the time to improve one grade, and the percentage improved at 4 weeks. Individually, many factors were associated with outcome. In the multivariate analysis, four factors correlate with poorer outcomes: mean amplitude of compound muscle action potential on stimulating distally of 20% of normal or less, older age, time from onset of disease of 7 days or less, and need for ventilatory support. The most powerful predictor of outcome was the abnormal mean amplitude of compound muscle action potential on stimulating distally. Plasmapheresis, the only variable the physician can influence, has a beneficial effect over and above any or all of these factors. The plasmapheresis patients on continuous flow machines had better outcomes than those on intermittent flow machines. From these data, tables of expected outcome probabilities have been developed.

摘要

相似文献

1
Plasmapheresis and Guillain-Barré syndrome: analysis of prognostic factors and the effect of plasmapheresis.
Ann Neurol. 1988 Apr;23(4):347-53. doi: 10.1002/ana.410230406.
2
Motor conduction studies in Guillain-Barré syndrome: description and prognostic value.吉兰-巴雷综合征的运动传导研究:描述及预后价值
Ann Neurol. 1988 Apr;23(4):354-9. doi: 10.1002/ana.410230407.
3
Plasmapheresis and acute Guillain-Barré syndrome. The Guillain-Barré syndrome Study Group.血浆置换与急性吉兰-巴雷综合征。吉兰-巴雷综合征研究组。
Neurology. 1985 Aug;35(8):1096-104.
4
Role of therapeutic plasmapheresis in the acute Guillain-Barré syndrome.治疗性血浆置换在急性吉兰-巴雷综合征中的作用。
J Neuroimmunol. 1988 Dec;20(2-3):297-300. doi: 10.1016/0165-5728(88)90177-4.
5
[Clinical and neurophysiologic study of Guillain Barré syndrome: results of therapy with plasmapheresis].
Riv Neurol. 1991 Jan-Feb;61(1):39-45.
6
[Treatment of Guillain-barre syndrome: immunoglobulins or plasmapheresis?].[吉兰-巴雷综合征的治疗:免疫球蛋白还是血浆置换?]
Neurologia. 1998 Apr;13(4):166-9.
7
The role of plasmapheresis in childhood Guillain-Barré syndrome.
Ann Neurol. 1990 Jul;28(1):65-9. doi: 10.1002/ana.410280112.
8
Landry Guillain-Barré Strohl syndrome in pregnancy: report of three cases treated with plasmapheresis.妊娠期兰德里-吉兰-巴雷-施特罗尔综合征:3例血浆置换治疗报告
Obstet Gynecol. 1991 Sep;78(3 Pt 2):482-5.
9
Plasma exchange treatment and prognosis of Guillain-Barré syndrome.吉兰-巴雷综合征的血浆置换治疗与预后
Q J Med. 1992 Oct;85(306):751-60.
10
Neuromuscular respiratory failure in Guillain-Barre Syndrome: evaluation of clinical and electrodiagnostic predictors.吉兰-巴雷综合征中的神经肌肉呼吸衰竭:临床及电诊断预测因素评估
J Assoc Physicians India. 2005 Sep;53:764-8.

引用本文的文献

1
Critical insights for intensivists on Guillain-Barré syndrome.给重症监护医生关于吉兰-巴雷综合征的关键见解。
Ann Intensive Care. 2025 May 21;15(1):67. doi: 10.1186/s13613-025-01464-w.
2
A Rare Guillain-Barré Syndrome Variant with Multi-Ganglioside Reactivity: A Case of Severe Cranial Nerve Involvement.一种具有多神经节苷脂反应性的罕见格林-巴利综合征变异型:一例严重颅神经受累病例
Rev Neurol. 2025 Feb 12;80(1):37744. doi: 10.31083/RN37744.
3
Three-year follow-up outcomes of adult patients with Guillain-Barré Syndrome after rehabilitation.
成人吉兰-巴雷综合征患者康复后 3 年随访结果。
Malawi Med J. 2023 Sep;35(3):156-162. doi: 10.4314/mmj.v35i3.4.
4
A Rare Case of Miller Fisher Syndrome in a 45-Year-Old Female.一名45岁女性患米勒-费雪综合征的罕见病例。
Cureus. 2023 Mar 20;15(3):e36387. doi: 10.7759/cureus.36387. eCollection 2023 Mar.
5
Assessing efficacy and safety of replacement fluids in therapeutic plasma exchange: A systematic scoping review of outcome measures used.评估治疗性血浆置换中替代液的疗效和安全性:使用的结局指标的系统范围评价综述。
J Clin Apher. 2022 Oct;37(5):438-448. doi: 10.1002/jca.21996. Epub 2022 Jun 21.
6
Post-COVID-19 Guillain-Barré Syndrome: A Case Report With Literature Review.新型冠状病毒肺炎后吉兰-巴雷综合征:一例病例报告并文献复习
Cureus. 2022 Jan 14;14(1):e21246. doi: 10.7759/cureus.21246. eCollection 2022 Jan.
7
Pharyngeal-Cervical-Brachial Variant of Guillain-Barré Syndrome.吉兰-巴雷综合征的咽-颈-臂变异型
Cureus. 2021 Oct 14;13(10):e18788. doi: 10.7759/cureus.18788. eCollection 2021 Oct.
8
Novel Immunological and Therapeutic Insights in Guillain-Barré Syndrome and CIDP.格林-巴利综合征和慢性炎症性脱髓鞘性多发性神经病的新免疫和治疗见解。
Neurotherapeutics. 2021 Oct;18(4):2222-2235. doi: 10.1007/s13311-021-01117-3. Epub 2021 Sep 21.
9
Therapeutic plasma exchange as a first-choice therapy for axonal Guillain-Barré syndrome: A case-based review of the literature (Review).治疗性血浆置换作为轴索性吉兰-巴雷综合征的首选治疗方法:基于病例的文献综述(综述)
Exp Ther Med. 2021 Mar;21(3):265. doi: 10.3892/etm.2021.9696. Epub 2021 Jan 25.
10
Initial Response and Outcome of Critically Ill Children With Guillain Barre' Syndrome.吉兰-巴雷综合征危重症患儿的初始反应及预后
Front Pediatr. 2019 Sep 18;7:378. doi: 10.3389/fped.2019.00378. eCollection 2019.